Live Oak Private Wealth’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.27M | Sell |
76,615
-69
| -0.1% | -$8.35K | 1.38% | 25 |
|
2025
Q1 | $8.55M | Buy |
76,684
+1,207
| +2% | +$135K | 1.39% | 27 |
|
2024
Q4 | $7.34M | Sell |
75,477
-696
| -0.9% | -$67.7K | 1.23% | 31 |
|
2024
Q3 | $8.76M | Sell |
76,173
-3,150
| -4% | -$362K | 1.42% | 23 |
|
2024
Q2 | $8.44M | Sell |
79,323
-1,072
| -1% | -$114K | 1.45% | 20 |
|
2024
Q1 | $7.78M | Sell |
80,395
-328
| -0.4% | -$31.7K | 1.35% | 25 |
|
2023
Q4 | $8.15M | Sell |
80,723
-528
| -0.6% | -$53.3K | 1.53% | 24 |
|
2023
Q3 | $8.28M | Buy |
81,251
+130
| +0.2% | +$13.2K | 1.76% | 17 |
|
2023
Q2 | $8.19M | Sell |
81,121
-365
| -0.4% | -$36.8K | 1.63% | 21 |
|
2023
Q1 | $7.5M | Buy |
81,486
+6,006
| +8% | +$553K | 1.55% | 24 |
|
2022
Q4 | $6.85M | Buy |
75,480
+901
| +1% | +$81.7K | 1.42% | 29 |
|
2022
Q3 | $5.67M | Buy |
74,579
+899
| +1% | +$68.3K | 1.27% | 32 |
|
2022
Q2 | $6.23M | Buy |
73,680
+1,734
| +2% | +$147K | 1.31% | 22 |
|
2022
Q1 | $6.31M | Buy |
71,946
+2,588
| +4% | +$227K | 1.22% | 33 |
|
2021
Q4 | $6.07M | Buy |
69,358
+2,792
| +4% | +$244K | 1.14% | 37 |
|
2021
Q3 | $5.44M | Buy |
66,566
+5,141
| +8% | +$420K | 1.11% | 39 |
|
2021
Q2 | $5.6M | Buy |
61,425
+3,564
| +6% | +$325K | 1.24% | 35 |
|
2021
Q1 | $4.95M | Buy |
57,861
+5,518
| +11% | +$472K | 1.21% | 36 |
|
2020
Q4 | $4.94M | Buy |
52,343
+4,274
| +9% | +$404K | 1.39% | 31 |
|
2020
Q3 | $4.18M | Sell |
48,069
-233
| -0.5% | -$20.3K | 1.44% | 32 |
|
2020
Q2 | $4.22M | Buy |
48,302
+45,418
| +1,575% | +$3.97M | 1.53% | 27 |
|
2020
Q1 | $238K | Buy |
+2,884
| New | +$238K | 0.24% | 64 |
|